Rapid regression of metastatic brain tumours in a melanoma patient after dabrafenib/trametinib therapy

Eur J Dermatol. 2017 Oct 1;27(5):548-549. doi: 10.1684/ejd.2017.3095.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary
  • Humans
  • Imidazoles / administration & dosage
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Oximes / administration & dosage
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Pyridones / administration & dosage
  • Pyrimidinones / administration & dosage
  • Remission Induction
  • Skin Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Oximes
  • Pyridones
  • Pyrimidinones
  • trametinib
  • Proto-Oncogene Proteins B-raf
  • dabrafenib